Response to Comments: MolDX: Repeat Germline Testing

This document is an administrative response to comments on the proposed MolDX policy DL38288-MolDX: Repeat Germline Testing and does not contain clinical coverage criteria. It records the public comment period (2019-10-07 to 2019-11-21), the notice period (2020-04-16 to 2020-05-31), and the LCD finalization date (2020-05-31). No indications, limitations, or frequency limits for clinical services are specified in the provided text.

"Administrative timeline: public comment period 2019-10-07 to 2019-11-21; notice period 2020-04-16 to 2020-05-31; LCD finalized on 2020-05-31."

Sign up to see full coverage criteria, indications, and limitations.